Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.39 |
| ▸ | LDHA | P00338 | 2/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.35 |
| ▸ | CCND1 | P24385 | 1/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116344 | 0.96 | TSPO (0.40) | KIF11LDHACYP11B2CCNE2CDK4 | |
| SCHEMBL22140545 | 0.92 | KIF11 (0.40) | KIF11LDHACYP11B2CCNE2CDK4 | |
| SCHEMBL17950234 | 0.91 | CYP11B2 (0.38) | KIF11LDHACYP11B2ACHE | |
| SCHEMBL17950236 | 0.91 | KIF11 (0.46) | KIF11LDHAALDH1A1 | |
| SCHEMBL26529151 | 0.88 | LDHA (0.40) | KIF11LDHACCNE2CDK4CCND1 | |
| SCHEMBL26529084 | 0.88 | LDHA (0.40) | KIF11LDHACCNE2CDK4CCND1 | |
| SCHEMBL26529170 | 0.88 | LDHA (0.40) | KIF11LDHACCNE2CDK4CCND1 | |
| SCHEMBL21116556 | 0.88 | LDHA (0.42) | KIF11LDHACYP11B2RXRARXRB | |
| SCHEMBL21116891 | 0.88 | KIF11 (0.39) | KIF11 | |
| SCHEMBL21116889 | 0.87 | KIF11 (0.41) | KIF11TSPOL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | KIF11 3544/4885LDHA 3375/4885CYP11B2 1090/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | KIF11 3520/4885LDHA 3458/4885CYP11B2 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.